Project Grant H8H45006

This federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940), aims to strengthen existing agreements and develop new strategies to re-engage people with HIV (PWH) who are not in care and outreach to those who are not virally suppressed in rural communities and municipalities in Puerto Rico. The $1,000,000 award to the Puerto Rico Department of Health (PRDOH) will...

This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) provides $15,351,606 to Cicatelli Associates, Inc. (CAI) to strengthen the capacity of health departments, community-based organizations, and the broader HIV prevention workforce. Specifically, CAI will deliver training and technical assistance services focused on promoting the adoption, implementation, and...

The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $7,888,424 Cooperative Agreement under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) to Healthhiv, a national non-profit organization based in Washington, DC. The award supports two key components: 1) eLearning training for high-impact HIV prevention programs, and 2) organization/workforce development and management for community-based...

The Centers for Disease Control and Prevention (CDC) awarded a $4,950,311 Cooperative Agreement under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) to Proceed Inc., doing business as the Puerto Rican Organization for Community Education and Economic Development, from August 2024 to March 2029. The award supports two key components: 1) Project REACH, which aims to enhance the capabilities of community-based organizations (CBOs) and health...

This Cooperative Agreement award, titled "MODELING HIV, VIRAL HEPATITIS, STI, AND TB TO IMPROVE PUBLIC HEALTH - CAMP 3.0: THE COALITION FOR APPLIED MODELING FOR PREVENTION", is funded by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The $2,745,600 award will support Emory University and its sub-awardees, the University of Washington, Oregon Health & Science University, and Johns Hopkins...

The U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA) awarded a $6,500,000 Project Grant under the HIV Emergency Relief Project Grants (CFDA 93.914) program to Georgetown University, in partnership with Boston University, Abt Global, and the Mayo Clinic. The grant's objectives are to: 1) enhance technical capacity and assist HRSA 25-063 recipients with implementing evidence-based HIV prevention and intervention strategies through innovative...

This $1,830,400 Cooperative Agreement, awarded by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940), supports the Prevention Policy Modeling Lab (PPML) led by Stanford University in partnership with multiple universities and public health departments. The PPML will develop disease models and advanced data analytics to enhance the evidence base for public health interventions and programs focused on HIV, viral...

This Project Grant award of $192,672 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is supporting Dr. Christopher Bennett of Stanford University in pursuing two key objectives: 1) investigating the cost-effectiveness of HIV screening in emergency departments (EDs) in Ending the HIV Epidemic (EHE) targeted areas compared to current screening rates, and determining the incremental...

This Project Grant award of $609,372 from the Department of Health and Human Services' National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) will support a research project titled "Leveraging Video Logs as a Bridge to Pre-Exposure Prophylaxis (PrEP) with Tailored Messaging to Black Women and Their Healthcare Providers in Texas." The primary objectives are to: 1) increase willingness for PrEP initiation and PrEP initiation among Black women,...